Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
1
x
$
30.00
A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae
1
x
$
30.00
6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients
1
x
$
30.00
Psychopharmacology Bulletin VOL 46 No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
1
x
$
0.00
Fobia social: perspectivas de diagnóstico, neurobiológicas y de tratamiento
1
x
$
0.00
Pharmacology of Valproate
1
x
$
30.00
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit
1
x
$
30.00
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
1
x
$
0.00
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
1
x
$
30.00
C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update
1
x
$
30.00
View Cart
Checkout
Home
Store
“C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
New Advances in the Management of Anxiety Disorders
$
30.00
Add to cart
Details
Gender-Specific Differences in Depression and Treatment Response
$
30.00
Add to cart
Details
Management of Late-Life Depression: Focus on Comorbid Conditions
$
30.00
Add to cart
Details
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
$
30.00
Add to cart
Details
Paroxetine Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Treatment of Panic Disorder: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
$
30.00
Add to cart
Details
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
$
30.00
Add to cart
Details
Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
$
30.00
Add to cart
Details
Paroxetine Use in Medically Ill Patients
$
30.00
Add to cart
Details
Paroxetine Treatment of Depression in Late Life
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
$
30.00
Add to cart
Details
Clinical Management of Perinatal Depression: Focus on Paroxetine
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
$
30.00
Add to cart
Details
Efficacy and Tolerability of Controlled-Release Paroxetine
$
30.00
Add to cart
Details
The History of Valproate in Clinical Neuroscience
$
30.00
Add to cart
Details
Previous
1
…
6
7
8
…
44
Next
Page load link
Go to Top
